236 related articles for article (PubMed ID: 34098344)
1. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer.
Fan J; Wang L; Chen M; Zhang J; Li J; Song F; Gu A; Yin D; Yi Y
World J Surg Oncol; 2022 Mar; 20(1):92. PubMed ID: 35321724
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive receptor LILRB1 acts as a potential regulator in hepatocellular carcinoma by integrating with SHP1.
Cheng J; Luan J; Chen P; Kuang X; Jiang P; Zhang R; Chen S; Cheng F; Gou X
Cancer Biomark; 2020; 28(3):309-319. PubMed ID: 32390601
[TBL] [Abstract][Full Text] [Related]
5. The Expression of ILT4 in Myeloid Dendritic Cells in Patients with Hepatocellular Carcinoma.
Wang L; Fan J; Ye W; Han J; Zhang Y; Zhao L; Duan J; Yin D; Yi Y
Immunol Invest; 2019 Oct; 48(7):704-718. PubMed ID: 31044626
[TBL] [Abstract][Full Text] [Related]
6. Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages.
Zeller T; Lutz S; Münnich IA; Windisch R; Hilger P; Herold T; Tahiri N; Banck JC; Weigert O; Moosmann A; von Bergwelt-Baildon M; Flamann C; Bruns H; Wichmann C; Baumann N; Valerius T; Schewe DM; Peipp M; Rösner T; Humpe A; Kellner C
Front Immunol; 2022; 13():929339. PubMed ID: 36389667
[TBL] [Abstract][Full Text] [Related]
7. HLA-G/LILRBs: A Cancer Immunotherapy Challenge.
Carosella ED; Gregori S; Tronik-Le Roux D
Trends Cancer; 2021 May; 7(5):389-392. PubMed ID: 33563576
[TBL] [Abstract][Full Text] [Related]
8. The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis.
Bylińska A; Wilczyńska K; Malejczyk J; Milewski Ł; Wagner M; Jasek M; Niepiekło-Miniewska W; Wiśniewski A; Płoski R; Barcz E; Roszkowski P; Kamiński P; Malinowski A; Wilczyński JR; Radwan P; Radwan M; Kuśnierczyk P; Nowak I
Mol Genet Genomics; 2018 Jun; 293(3):601-613. PubMed ID: 29234882
[TBL] [Abstract][Full Text] [Related]
9. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.
McIntire RH; Sifers T; Platt JS; Ganacias KG; Langat DK; Hunt JS
Placenta; 2008 Jul; 29(7):631-8. PubMed ID: 18538388
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
[TBL] [Abstract][Full Text] [Related]
11. Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance.
Li X; Wei X; Xu H; Sha Z; Gao A; Sun Y; Li J; Xu L
J Cancer Res Ther; 2018; 14(7):1655-1659. PubMed ID: 30589055
[TBL] [Abstract][Full Text] [Related]
12. LILRB receptor-mediated regulation of myeloid cell maturation and function.
van der Touw W; Chen HM; Pan PY; Chen SH
Cancer Immunol Immunother; 2017 Aug; 66(8):1079-1087. PubMed ID: 28638976
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytomegalovirus infection and leukocyte immunoglobulin like receptor B1 polymorphisms on receptor expression in peripheral blood mononuclear cells.
Cadena-Mota S; Monsiváis-Urenda A; Salgado-Bustamante M; Monjarás-Ávila C; Bernal-Silva S; Aranda-Romo S; Noyola DE
Microbiol Immunol; 2018 Dec; 62(12):755-762. PubMed ID: 30461037
[TBL] [Abstract][Full Text] [Related]
14. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.
HoWangYin KY; Loustau M; Wu J; Alegre E; Daouya M; Caumartin J; Sousa S; Horuzsko A; Carosella ED; LeMaoult J
Cell Mol Life Sci; 2012 Dec; 69(23):4041-9. PubMed ID: 22802125
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
[TBL] [Abstract][Full Text] [Related]
16. Characterization and functional analyses of novel chicken leukocyte immunoglobulin-like receptor subfamily B members 4 and 5.
Truong AD; Hong Y; Tran HTT; Dang HV; Nguyen VK; Pham TT; Lillehoj HS; Hong YH
Poult Sci; 2019 Dec; 98(12):6989-7002. PubMed ID: 31376355
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
[TBL] [Abstract][Full Text] [Related]
18. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory leukocyte immunoglobulin-like receptors in cancer development.
Zhang F; Zheng J; Kang X; Deng M; Lu Z; Kim J; Zhang C
Sci China Life Sci; 2015 Dec; 58(12):1216-25. PubMed ID: 26566804
[TBL] [Abstract][Full Text] [Related]
20. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
